Antibody Microarrays for Urinary Proteome Profiling

Renal and Urinary Proteomics: Methods and Protocols

Volumn , Issue , 2009, Pages 349-366

  Liu, Bi Cheng ^a   Lv, Lin Li ^a   Zhang, Lu ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Ambient analyte; Antibody microarray; Biomarker; Kidney disease; Ligand binding assays; Microspots; Proteomics; Sandwich immunoassay; Urinary proteome

Indexed keywords

EID: 84889462959     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527628612.ch26     Document Type: Chapter

References (111)

1. MacBeath, G. (2002) Protein microarrays and proteomics. Nat Genet, 32, 526-532.
2. Barry, R. and Soloviev, M. (2004) Quantitative protein profiling using antibody arrays. Proteomics, 4 (12), 3717-3726.
3. Wingren, C. and Borrebaeck, C.A. (2006) Antibody microarrays: current status and key technological advances. OMICS, 10 (3), 411-427.
4. Ling, M.M., Ricks, C., and Lea, P. (2007) Multiplexing molecular diagnostics and immunoassays using emerging microarray technologies. Expert Rev Mol Diagn, 7 (1), 87-98.
5. Ekins, R., Chu, F., and Biggart, E. (1990) Multispot, multianalyte, immunoassay. Ann Biol Clin, 48, 655-666.
6. MacBeath, G. and Schreiber, S.L. (2000) Printing proteins as microarrays for high-throughput function determination. Science, 289 (5485), 1760-1763.
7. Lia, Y., Schuttea, R.J., Abu-Shakra, A. et al. (2005) Protein array method for assessing in vitro biomaterial-induced cytokine expression. Biomaterials, 26, 1081-1085.
8. Sukhanov, S. and Delafontaine, P. (2005) Protein chip-based microarray profiling of oxidized low density lipoprotein-treated cells. Proteomics, 5, 1274-1280.
9. Relucio, K.I., Beernink, H.T., Chen, D. et al. (2005) Proteomic analysis of serum cytokine levels in response to highly active antiretroviral therapy (HAART). J Proteome Res, 4, 227-231.
10. Srivastava, M., Eidelman, O., Jozwik, C. et al. (2006) Serum proteomic signature for cystic fibrosis using an antibody microarray platform. Mol Genet Metab, 87 (4), 303-310.
11. Ivanov, S.S., Chung, A.S., Yuan, Z. et al. (2004) Antibodies immobilized as arrays to profile protein post-translational modifications in mammalian cells. Mol Cell Proteomics, 3 (8), 788-795.
12. Eisenstein, M. (2006) Protein arrays: growing pains. Nature, 444 (7121), 959-962.
13. Templin, M.F., Stoll, D., Schrenk, M. et al. (2002) Protein microarray technology. Trends Biotechnol, 20 (4), 160-166.
14. Saviranta, P., Okon, R., and Brinker, A. (2004) Evaluating sandwich immunoassays in microarray format in terms of the ambient analyte regime. Clin Chem, 50 (10), 1907-1920.
15. Kusnezow, W., Syagailo, Y.V., Ruffer, S. et al. (2006) Kinetics of antigen binding to antibody microspots: strong limitation by mass transport to the surface. Proteomics, 6 (3), 794-803.
16. Haab, B.B., Dunham, M.J., and Brown, P.O. (2001) Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol, 2, RESEARCH0004.
17. Huang, R.P. (2001) Detection of multiple proteins in an antibody-based protein microarray system. J Immunol Methods, 255 (1-2), 1-13.
18. Ahn, E.H., Kang, D.K., Chang, S.I. et al. (2006) Profiling of differential protein expression in angiogenin-induced HUVECs using antibody-arrayed ProteoChip. Proteomics, 6 (4), 1104-1109.
19. Nielsena, U.B. and Geierstanger, B.H. (2004) Multiplexed sandwich assays in microarray format. J Immunol Methods, 290, 107-120.
20. Phizicky, E., Bastiaens, P.I.H., Zhu, H. et al. (2003) Protein analysis on a proteomic scale. Nature, 422 (13), 208-215.
21. Song, S., Li, B., Wang, L. et al. (2007) A cancer protein microarray platform using antibody fragments and its clinical applications. Mol Biosyst, 3 (2), 151-158.
22. Shao, W., Zhou, Z., Laroche, I. et al. (2003) Optimization of rolling-circle amplified protein microarrays for multiplexed protein profiling. J Biomed Biotechnol, 5, 299-307.
23. Haab, B.B. (2005) Antibody arrays in cancer research. Mol Cell Proteomics, 4, 377-383.
24. Haab, B.B. Paulovich, A.G., Anderson, N.L. et al. (2006) A reagent resource to identify proteins and peptides of interest for the cancer community: a workshop report. Mol Cell Proteomics, 5 (10), 1996-2007.
25. Wingren, C., Ingvarsson, J., Lindstedt, M. et al. (2003) Recombinant antibody microarrys-a viable option? Nat Biotechnol, 21, 223.
26. Chambers, R.S. (2005) High-throughput antibody production. Curr Opin Chem Biol, 9 (1), 46-50.
27. Michaud, G.A., Salcius, M., and Zhou, F. (2003) Analyzing antibody specificity with whole proteome microarrays. Nat Biotechnol, 21 (12), 1509-1512.
28. Kozarova, A., Petrinac, S., Ali, A. et al. (2006) Array of informatics: applications in modern research. J Proteome Res, 5 (5), 1051-1059.
29. Doerr, A. (2005) Protein microarray velcro. Nat Methods, 2 (9), 642-643.
30. Angenendt, P. (2005) Progress in protein and antibody microarray technology. Drug Discov Today, 10 (7), 503-511.
31. Angenendt, P., Glokler, J., Murphy, D. et al. (2002) Toward optimized antibody microarrays: a comparison of current microarray support materials. Anal Biochem, 309 (2), 253-260.
32. Guilleaume, B., Buness, A., Schmidt, C. et al. (2005) Systematic comparison of surface coatings for protein microarrays. Proteomics, 5 (18), 4705-4712.
33. Kusnezow, W., Jacob, A., Walijew, A. et al. (2003) Antibody microarrays: an evaluation of production parameters. Proteomics, 3 (3), 254-264.
34. Arenkov, P., Kukhtin, A., Gemmell, A. et al. (2000) Protein microchips: use for immunoassay and enzymatic reactions. Anal Biochem, 278 (2), 123-131.
35. Fesenko, D.O., Nasedkina, T.V., Prokopenko, D.V. et al. (2005) Biosensing and monitoring of cell populations using the hydrogel bacterial microchip. Biosens Bioelectron, 20 (9), 1860-1865.
36. Rubina, A.Y., Dementieva, E.I., Stomakhin, A.A. et al. (2003) Hydrogel-based protein microchips: manufacturing, properties, and applications. Biotechniques, 34 (5), 1008-1014, 1016-1020, 1022.
37. Afanassiev, V., Hanemann, V., and Wölfl, S. (2000) Preparation of DNA and protein micro arrays on glass slides coated with an agarose film. Nucleic Acids Res, 28, E66.
38. Jin, S.H., Liu, B.C., Zhang, C.X. et al. (2005) Optimizing of the preparation condition of agarose modified glass slide for the production of protein microarray. Chin J Biotechnol, 25, 57-60.
39. Zhang, C.X., Liu, H.P., Tang, Z.M. et al. (2003) Cell detection based on protein array using modified glass slides. Electrophoresis, 24, 3279-3283.
40. Lv, L.L., Liu, B.C., Zhang, C.X. et al. (2007) Construction of an antibody microarray based on agarose-coated slides. Electrophoresis, 28, 406-413.
41. Vareiro, M.M., Liu, J., Knoll, W. et al. (2005) Surface plasmon fluorescence measurements of human chorionic gonadotrophin: role of antibody orientation in obtaining enhanced sensitivity and limit of detection. Anal Chem, 77, 2426-2431.
42. Wu, P. and Grainger, D.W. (2006) Comparison of hydroxylated print additives on antibody microarray performance. J Proteome Res, 5 (11), 2956-2965.
43. Wu, P. and Grainger, D.W. (2004) Toward immobilized antibody microarray optimization: print buffer and storage condition comparisons on performance. Biomed Sci Instrum, 40, 243-248.
44. Kukar, T., Eckenrode, S., Gu, Y. et al. (2002) Protein microarrays to detect protein-protein interactions using red and green fluorescence proteins. Anal Biochem, 306 (1), 50-54.
45. Espina, V., Woodhouse, E.C., Wulfkuhle, J. et al. (2004) Protein microarray detection strategies: focus on direct detection technologies. J Immunol Methods, 290 (1-2), 121-133.
46. Müller, U.R. (2003) Evolution of high-sensitivity microarray technology. J Assoc Lab Autom, 8, 96-100.
47. Chan, W.C. and Nie, S. (1998) Quantum dot bioconjugates ultrasensitive nonisotopic detection. Science, 281 (5385), 2016-2018.
48. Nettikadan, S., Radke, K., Johnson, J. et al. (2006) Detection and quantification of protein biomarkers from fewer than 10 cells. Mol Cell Proteomics, 5 (5), 895-901.
49. Kusnezow, W., Syagailo, Y.V., Ruffer, S. et al. (2006) Kinetics of antigen binding to antibody microspots: strong limitation by mass transport to the surface. Proteomics, 6, 794-803.
50. Drukier, A.K., Ossetrova, N., Schors, E. et al. (2005) Ultra-sensitive immunoassays using multi-photon-detection in diagnostic proteomics of blood. J Proteome Res, 4 (6), 2375-2378.
51. Kingsmore, S.F. and Patel, D.D. (2003) Multiplex protein profiling on antibody-based microarrays by rolling circle amplification. Curr Opin Biotechnol, 14 (1), 74-81.
52. Woodbury, R.L., Varnum, S.M., and Zangar, R.C. (2002) Elevated HGF levels in sera from breast cancer patients detected using a protein microarray ELISA. J Proteome Res, 1 (3), 233-237.
53. Ingvarsson, J., Lindstedt, M., Borrebaeck, C.A. et al. (2006) One-step fractionation of complex proteomes enables detection of low abundant analytes using antibody-based microarrays. J Proteome Res, 5 (1), 170-176.
54. Kusnezow, W., Syagailo, Y.V., Goychuk, I. et al. (2006) Antibody microarrays: the crucial impact of mass transport on assay kinetics and sensitivity. Expert Rev Mol Diagn, 6 (1), 111-124.
55. Hartmann, M., Toeglb, A., Kirchner, R. et al. (2006) Increasing robustness and sensitivity of protein microarrays through microagitation and automation. Anal Chim Acta, 564, 66-73.
56. Knight, P.R., Sreekumar, A., Siddiqui, J. et al. (2004) Development of a sensitive microarray immunoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis. Shock, 21 (1), 26-30.
57. Ivanov, S.S., Chung, A.S., Yuan, Z.L. et al. (2004) Antibodies immobilized as arrays to profile protein post-translational modifications in mammalian cells. Mol Cell Proteomics, 3 (8), 788-795.
58. Delom, F. and Chevet, E. (2006) Phosphoprotein analysis: from proteins to proteomes. Proteome Sci, 4, 15, DOI: 10.1186/1477-5956-4-15.
59. Kozarova, A., Petrinac, S., Ali, A. et al. (2006) Array of informatics: applications in modern research. J Proteome Res, 5, 1051-1059.
60. Collett, J.R., Cho, E.J., and Ellington, A.D. (2005) Production and processing of aptamer microarrays. Methods, 37, 4-15.
61. Hanash, S. (2003) Disease proteomics. Nature, 422 (13), 226-232.
62. Renberg, B., Nordin, J., Merca, A. et al. (2007) Affibody molecules in protein capture microarrays: evaluation of multidomain ligands and different detection formats. J Proteome Res, 6 (1), 171-179.
63. Boyle, M.D., Hess, J.L., Nuara, A.A. et al. (2006) Application of immunoproteomics to rapid cytokine detection. Methods, 38 (4), 342-350.
64. Hultschig, C., Kreutzberger, J., Seitz, H. et al. (2006) Recent advances of protein microarrays. Curr Opin Chem Biol, 10, 4-10.
65. Eckel-Passow, J.E., Hoering, A., and Therneau, T.M. (2005) Ghobrial I: experimental design and analysis of antibody microarrays: applying methods from cDNA arrays. Cancer Res, 65, 2985-2989.
66. Espina, V., Mehta, A.I., Winters, M.E. et al. (2003) Protein microarrays: molecular profiling technologies for clinical specimens. Proteomics, 3, 2091-2100.
67. Collins, C.D., Purohit, S., Podolsky, R.H. et al. (2006) The application of genomic and proteomic technologies in predictive, preventive and personalized medicine. Vascul Pharmacol, 45 (5), 258-267.
68. Haab, B.B. (2006) Using array-based competitive and noncompetitive immunoassays. AACR 97th Annual Meeting, Washington, DC, United States, April 1-5, 2006.
69. Nielsen, U.B., Mike, H., Cardone, M.H., Sinskey, A.J. et al. (2003) Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc Natl Acad Sci U S A, 100 (16), 9330-9335.
70. Gembitsky, D.S., Lawlor, K., Jacovina, A. et al. (2004) A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation. Mol Cell Proteomics, 3 (11), 1102-1118.
71. Srivastava, M., Eidelman, O., Jozwik, C. et al. (2006) Serum proteomic signature for cystic Wbrosis using an antibody microarray platform. Mol Genet Metab, 87, 303-310.
72. Sreekumar, A., Nyati, M.K., Varambally, S. et al. (2001) Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res, 61 (20), 7585-7593.
73. Weber, A., Hengge, U.R., Stricker, I. et al. (2007) Protein microarrays for the detection of biomarkers in head and neck squamous cell carcinomas. Hum Pathol, 38 (2), 228-238.
74. Harris, D.C.H. and Rangan, G.K. (2005) Retardation of kidney failure - applying principles to practice. Ann Acad Med Singapore, 34, 16-23.
75. Wong, W. and Singh, A.K. (2001) Urinary cytokines: clinically useful markers of chronic renal disease progression? Curr Opin Nephrol Hypertens, 10 (6), 807-811.
76. Susztak, K., Sharma, K., Schiffer, M. et al. (2003) Genomic strategies for diabetic nephropathy. J Am Soc Nephrol, 14, S271-S278.
77. Knepper, M.A. (2002) Proteomics and the kidney. J Am Soc Nephrol, 13, 1398-1408.
78. Liu, B.C., Zhang, L., Lv, L.L. et al. (2006) Application of antibody array technology in analysis of urinary cytokine profiles in patients with chronic kidney disease. Am J Nephrol, 26 (5), 483-490.
79. Mosley, K., Tam, F.W., Edwards, R.J. et al. (2006) Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology, 45, 1497-1504.
80. Thongboonkerd, V. and Klein, J.B. (eds) (2004) Overview of proteomics, Proteomics in Nephrology, Contributions to Nephrology, vol. 141, Karger, Basel, pp. 1-10.
81. Aebersold, R., Anderson, L., Caprioli, R. et al. (2005) Perspective: a program to improve protein biomarker discovery for cancer. J Proteome Res, 4, 1104-1109.
82. Aderson, L. (2005) Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol, 563 (1), 23-60.
83. Fliser, D., Novak, J., Thongboonkerd, V. et al. (2007) Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol, 18 (4), 1057-1071.
84. Dihazi, H. and Muller, G.A. (2007) Urinary proteomics: a tool to discover biomarkers of kidney diseases. Expert Rev Proteomics, 4 (1), 39-50.
85. Pisitkun, T., Johnstone, R., and Knepper, M.A. (2006) Discovery of urinary biomarkers. Mol Cell Proteomics, 5 (10), 1760-1771.
86. Anderson, P., Parallel Sample Preparation for Proteomics Applications. Cambridge Healthtech Institute's Second Annual Conference, Genomic and proteomic sample preparation. Boston, MA, May 2-3, 2002.
87. Gonzalez-Buitrago, J.M., Ferreira, L., and Lorenzo, I. (2007) Urinary proteomics. Clin Chim Acta, 375 (1-2), 49-56.
88. O'Riordan, E., Gross, S.S., and Goligorsky, M.S. (2006) Technology Insight: renal proteomics - at the crossroads between promise and problems. Nat Clin Pract Nephrol, 2 (8), 445-458.
89. Parikh, C.R., Abraham, E., Ancukiewicz, M. et al. (2005) Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol, 16, 3046-3052.
90. Kassir, K., Vargas-Shiraishi, O., Zaldivar, F. et al. (2001) Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: potential therapeutic impact. Clin Diagn Lab Immunol, 8 (6), 1060-1063.
91. Aldreda, S., Grantb, M.M., and Griffiths, H.R. (2004) The use of proteomics for the assessment of clinical samples in research. Clin Biochem, 37, 943-952.
92. Steel, L.F., Trotter, M.G., Nakajima, P.B. et al. (2003) Efficient and specific removal of albumin from human serum samples. Mol Cell Proteomics, 2 (4), 262-270.
93. Schaub, S., Wilkins, J., Weiler, T. et al. (2004) Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int, 65, 323-332.
94. Rogers, M.A., Clarke, P., Noble, J. et al. (2003) Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res, 63, 6971-6983.
95. Hostetter, T.H. (2003) Prevention of the development and progression of renal disease. J Am Soc Nephrol, 14, S144-S147.
96. Hewitt, S.M., Dear, J., and Star, R.A. (2004) Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol, 15, 1677-1689.
97. Vidal, B.C., Bonventre, J.V., and I-Hong Hsu, S. (2005) Towards the application of proteomics in renal disease diagnosis. Clin Sci (Lond), 109 (5), 421-430.
98. Ramitez, S.B. (2003) First international summit on kidney disease prevention, 25-27 July 2002: consensus document. J Am Soc Nephrol, 14, S205-S207.
99. Sharma, K., SoHee Lee, S., Han, S. et al. (2005) Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics, 5, 2648-2655.
100. Schaub, S., Rush, D., Wilkins, J. et al. (2004) Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol, 15, 219-227.
101. Mosley, K., Tam, F.W., Edwards, R.J. et al. (2006) Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology (Oxford), 45 (12), 1497-1504.
102. Zoccali, C. (2005) Biomarkers in chronic kidney disease: utility and issues towards better understanding. Curr Opin Nephrol Hypertens, 14, 532-537.
103. Nagasawa, Y., Takenaka, M., Kaimori, J. et al. (2001) Rapid and diverse changes of gene expression in the kidneys of protein-overload proteinuria mice detected by microarray analysis. Nephrol Dial Transplant, 16 (5), 923-931.
104. Weber, A., Hengge, U.R., Stricke, I. et al. (2007) Protein microarrays for the detection of biomarkers in head and neck squamous cell carcinomas. Hum Pathol, 38 (2), 228-238.
105. Mor, G., Visintin, I., Lai, Y. et al. (2005) Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci U S A, 102 (21), 7677-7682.
106. Anderson, N.L. (2005) The roles of multiple proteomic platforms in a pipeline for new diagnostics. Mol Cell Proteomics, 4 (10), 1441-1444.
107. Urbanowska, T., Mangialaio, S., Zickler, C. et al. (2006) Protein microarray platform for the multiplex analysis of biomarkers in human sera. J Immunol Methods, 316 (1-2), 1-7.
108. Azad, N.S., Rasool, N., Annunziata, C.M. et al. (2006) Proteomics in clinical trials and practice: present uses and future promise. Mol Cell Proteomics, 5 (10), 1819-1829.
109. Wu, T. and Mohan, C. (2007) Proteomics on the diagnostic horizon: lessons from rheumatology. Am J Med Sci, 333 (1), 16-25.
110. Master, S.R., Bierl, C., and Kricka, L.J. (2006) Diagnostic challenges for multiplexed protein microarrays. Drug Discov Today, 11 (21-22), 1007-1011.
111. Hamelinck, D., Zhou, H., Li, L., Verweij, C. et al. (2005) Optimized normalization for antibody microarrays and application to serum-protein profiling. Mol Cell Proteomics, 4 (6), 773-784.